Skip to main content

Table 4 Descriptive summaries of patient’s for HF data set

From: Assessing survival time of heart failure patients: using Bayesian approach

Patients status
Covariates Categories Number of censored (%) Number of death (%) Total
Sex Female 148 (60.41) 68 (41.46) 216 (52.81)
Male 97 (39.59) 96 (58.54) 193 (47.19)
Age  ≤ 49 98 (40.0) 17 (10.36) 115 (28.12)
49–65 78 (31.84) 53 (32.32) 131 (32.03)
 ≥ 65 69 (28.16) 94 (57.32) 163 (39.85)
Alcohol No 172 (70.20) 92 (56.10) 264 (64.55)
Yes 73 (29.80) 72 (43.90) 145 (35.45)
Place of residence Urban 97 (39.59) 47 (28.66) 144 (35.21)
Rural 148 (60.41) 117 (71.34) 265 (64.79)
History of heart failure New 74 (30.20) 46 (28.05) 120 (29.34)
HF patient before 84 (34.29) 79 (48.17) 163 (39.85)
Medical OPD 87 (35.51) 39 (23.78) 126 (30.81)
Chronic kidney disease No 224 (91.43) 61 (37.20) 285 (69.68)
Yes 21 (8.57) 103 (62.80) 124 (30.32)
Hypertension No 203 (82.86) 45 (27.44) 248(60.64)
Yes 42 (17.14) 119 (72.56) 161 (39.36)
Anemia No 205 (83.67) 62 (37.80) 267 (65.28)
Yes 40 (16.33) 102 (62.20) 142 (34.72)
Diabetes mellitus Not 204 (83.26) 34 (20.73) 238 (58.19)
Type I 18 (7.35) 38 (23.17) 56 (13.69)
Type II 23 (9.39) 92 (57.0) 115 (28.12)
Etiology of heart failure IHD 62 (25.31) 20 (12.19) 82 (20.05)
RVHD 47 (19.18) 44 (26.83) 91 (22.25)
Cardiomyopathy 55 (22.45) 42 (25.61) 97 (23.72)
HHD 55 (22.45) 49 (29.88) 104 (25.43)
Others 26 (10.61) 9 (5.49) 35 (8.55)
Smoking cigarette No 232 (94.69) 74 (45.12) 306 (74.82)
Yes 13 (5.31) 90 (54.88) 103 (25.18)
Treatments taken Digoxin 48 (19.59) 31 (18.90) 79 (19.32)
Spironolactone 65 (26.53) 34 (20.73) 99 (24.20)
Atorvastatin 62 (25.31) 41 (25.0) 103 (25.18)
Others 27 (11.02) 20 (12.20) 47 (11.49)
Combination ≥ 2 43 (17.55) 38 (23.17) 81 (19.80)
Stages of heart failure I 58 (23.67) 5 (3.05) 63 (15.40)
II 61 (24.90) 17 (10.37) 78 (19.07)
III 65 (26.53) 52 (31.71) 117 (28.61)
IV 61 (24.90) 90 (54.87) 151 (36.92)
  1. IHD, Ischemic heart disease; RVHD, Rheumatic valvular heart disease; and HHD, Hypertensive heart disease. Source: JUMC, Jimma, Ethiopia; from first January 2016 to first January 2019